Product Images Ibandronate Sodium
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 5 images provide visual information about the product associated with Ibandronate Sodium NDC 60505-6097 by Apotex Corp., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1 - Ibandronate 01
This text appears to be discussing two different dosage options for increasing Lumbar Spine BMD (bone mineral density) and their effectiveness. The first option is a daily 2.5mg dose, while the second option is a 3mg dose given once every three months either orally or intravenously. The study mentioned compared the two dosages and found that the 3mg every 3 months was more effective, with a statistically significant difference (p<0.001).*
Figures 2 - Ibandronate 02
Ibandronate-04 - Ibandronate 04
Ibandronate-05 - Ibandronate 05
Ibandronate Sodium Injection is a sterile, single-use, prefilled syringe with a quantity of 3 mg*/3 mL (1 mg/mL), to be used intravenously only. It contains Ibandronate sodium monohydrate, equivalent to 3 mg ibandronate free acid. It is accompanied by prescribing information and should be stored at temperatures between 15°C-30°C (59°F-86°F). Unused portions of the solution should be discarded. It is manufactured in India by Gland Pharma Limited and distributed by Apotex Corp. in Weston, Florida.*
Chemical Structure - structure
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.